{"id":484403,"title":"Good clinical practices: Guidance documents - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T23:31:28.434000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents.html?wbdisable=true","snippet":"Good clinical practices: Guidance documents Guidance Document: Part C, Division 5 of the Food and Drug Regulations \"Drugs for Clinical Trials Involving Human Subjects\" (GUI-0100) Risk classification guide for observations related to inspections of clinical trials of human drugs…","rawSnapshotUrl":"/api/snapshots/raw/484403","browseUrl":"https://replay.healtharchive.ca/job-6/20260106233128/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents.html?wbdisable=true#ha_snapshot=484403","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}